Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Regulatory
Cyklokapron — CYKLOKAPRON
Application NDA019281 (NDA)
Cyklokapron — CYKLOKAPRON
Application NDA019280 (NDA)
Cyklokapron — LYSTEDA
Application NDA022430 (NDA)
Cyklokapron — TRANEXAMIC ACID
Application NDA212020 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)